Smart sensors could track brain disease at home

NCT ID NCT07240805

Not yet recruiting Knowledge-focused Sponsor: BioSensics Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 5 times

Summary

This study will test whether wearable sensors can accurately monitor movement problems in people with progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). About 60 participants will wear small sensors on their chest, ankles, and wrists while doing simple tasks like walking and hand movements, both in the clinic and at home for 14 days. The goal is to see if these sensors can provide reliable, at-home monitoring that could be used in future clinical trials for these rare brain diseases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
wearable sensors (PAMSys pendant, ankle, and wrist sensors)
What this could lead to
If successful, this could enable frequent, at-home monitoring of disease symptoms, making future clinical trials more efficient and less burdensome for patients.
What could go wrong
This is an early-stage validation study with only 60 participants, so the sensors may not prove accurate or practical for widespread use. The results are observational and won't directly treat or cure the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES (DLB) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins University School of Medicine

    Lutherville, Maryland, 21093, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.